Published ahead of print on March 2, 2006, doi:10.1164/rccm.200506-916OC
Am. J. Respir. Crit. Care Med., Volume 173, Number 11, June 2006, 1270-1275
A more recent version of this article appeared on June 1, 2006
Submitted on June 14, 2005
Accepted on February 28, 2006
Fibrinogen from Patients with Chronic Thromboembolic Pulmonary Hypertension is Resistant to Lysis
Timothy A Morris1*, James J Marsh1, Peter G Chiles1, William R Auger1, Peter F Fedullo1, and Virgil L Woods Jr.2
1 Department of Medicine, University of California, Division of Pulmonary/Critical Care Medicine, San Diego, California, USA,
2 Department of Medicine and Biomedical Sciences Graduate Program, University of California, San Diego, California, USA
* To whom correspondence should be addressed. E-mail: t1morris{at}ucsd.edu.
Rationale: Although acute pulmonary embolism is epidemiologically associated with chronic thromboembolic pulmonary hypertension, the factors responsible for resistance to thrombolysis and a shift toward vascular remodeling within the pulmonary arteries of patients with chronic thromboembolic pulmonary hypertension are unknown. Objective: Determine whether fibrin from patients is more resistant to plasmin-mediated lysis than fibrin from healthy controls. Methods: Fibrinogen purified from patients and controls was used to prepare fibrin clots, which were subsequently digested with plasmin for various periods of time. The degradation of the -, -, and -chains of fibrin and the appearance of peptide fragments over time were assessed by polyacrylamide gel electrophoresis and western blotting. Measurements and Main Results: Densitometry of Coomassie-stained gels revealed significantly slower cleavage of all three polypeptide chains of fibrin from patients compared to controls (P<0.05). In particular, release of N- terminal fragments from the -chain of fibrin, which promote cell signaling, cell migration and angiogenesis, was retarded in patients compared to controls (P<0.01). Conclusions: The relative resistance of patient fibrin to plasmin-mediated lysis may be due to alterations in fibrin(ogen) structure affecting accessibility to plasmin cleavage sites. The persistence of structural motifs of fibrin, such as the -chain N-terminus, within the pulmonary vasculature could promote the transition from acute thromboemboli into chronic, obstructive vascular scars.
Key words: Pulmonary Hypertension; Pulmonary Embolism; Thrombosis; Fibrinolysis; Fibrinogen
This article has been cited by other articles:

|
 |

|
 |
 
M. Xu, C. V. Remillard, B. D. Sachs, A. Makino, O. Platoshyn, W. Yao, W. H. Dillmann, K. Akassoglou, and J. X.-J. Yuan
p75 neurotrophin receptor regulates agonist-induced pulmonary vasoconstriction
Am J Physiol Heart Circ Physiol,
October 1, 2008;
295(4):
H1529 - H1538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Suntharalingam, K. Goldsmith, V. van Marion, L. Long, C. M. Treacy, F. Dudbridge, M. R. Toshner, J. Pepke-Zaba, J. C. J. Eikenboom, and N. W. Morrell
Fibrinogen A{alpha} Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension
Eur. Respir. J.,
April 1, 2008;
31(4):
736 - 741.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 American Thoracic Society
|
|
|